We have been studying a nuclear protease, which appears to be involved in cellular transformation, as well as in infections with high-risk human papillomaviruses (HPVs). This protease has a chymotrypsin-like substrate specificity and the chloromethylketone inhibitor AAPF(CMK) is a potent (and relatively selective) inhibitor of it. Recently, we have observed that AAPF(CMK) has potent effects in some model systems which appear not to be mediated by decreases in the nuclear protease. Here we show that AAPF(CMK) selectively reacts with ATP-dependent helicases as well as a limited spectrum of proteins in other DNA repair/chromatin remodeling nuclear complexes, including for example Cohesin complex components and proteins containing SAP-domains. In vitro, AAPF(CMK) selectively reacts with SV40 large T antigen, and inhibits its helicase activity.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/jcb.21021 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
An unexpected switch in peptide binding mode: from simulation to substrate specificity.
J Biomol Struct Dyn
November 2018
a Faculty of Chemistry and Pharmacy, Institute of General, Inorganic and Theoretical Chemistry , University Innsbruck, Innrain 82, Innsbruck A-6020 , Austria.
Article Synopsis
- A molecular dynamics simulation lasting ten microseconds revealed an unexpected change in how a kallikrein-related peptidase 7 peptide complex binds, showing a 180° rotation around the P1 residue.
- The binding pose shifts to occupy the prime side region instead of the non-prime side, and this new binding mode is analyzed through various molecular properties and compared with existing inhibitors.
- The study also incorporates in silico mutagenesis to investigate the specificity of the binding on the prime side, providing valuable insights that could aid in the development of targeted inhibitors for treating skin diseases and cancer.
Mechanisms of growth inhibition in human papillomavirus positive and negative cervical cancer cells by the chloromethyl ketone protease inhibitor, succinyl-alanine-alanine-proline-phenylalanine chloromethyl ketone.
J Pharmacol Exp Ther
July 2009
Jake Gittlen Cancer Research Foundation, Pennsylvania State University College of Medicine, 500 University Drive, Hershey, PA 17033, USA.
The chymotrypsin-like serine protease inhibitor, succinyl-alanine-alanine-proline-phenylalanine chloromethyl ketone (AAPF(CMK)), has been shown to have anticarcinogenic activity in a number of model systems and to be relatively selective for a nuclear protease. This inhibitor also has substantial effects on growth of tumorigenic human papillomavirus (HPV)-infected keratinocytes in organotypic raft cultures. Here, we examined the effects of AAPF(CMK) on cell growth, cell-cycle kinetics, apoptosis induction, and DNA synthesis in two human cervical carcinoma cell lines: SiHa cells, which have integrated high-risk HPV-16; and C33a cells, which do not contain HPV DNA.
View Article and Find Full Text PDFThe chloromethylketone protease inhibitor AAPF(CMK) also targets ATP-dependent helicases and SAP-domain proteins.
J Cell Biochem
February 2007
Gittlen Cancer Research Foundation, Pennsylvania State University, Hershey, PA 17033, USA.
We have been studying a nuclear protease, which appears to be involved in cellular transformation, as well as in infections with high-risk human papillomaviruses (HPVs). This protease has a chymotrypsin-like substrate specificity and the chloromethylketone inhibitor AAPF(CMK) is a potent (and relatively selective) inhibitor of it. Recently, we have observed that AAPF(CMK) has potent effects in some model systems which appear not to be mediated by decreases in the nuclear protease.
View Article and Find Full Text PDFA protease inhibitor specifically inhibits growth of HPV-infected keratinocytes.
Mol Ther
June 2006
The Jake Gittlen Cancer Research Institute, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.
Protease inhibitors have been known to exhibit anticarcinogenic activity in a variety of model systems, although the biological target(s) and mechanism remain enigmatic. Human papillomavirus (HPV) is the primary etiological agent of cervical cancer. Here we show that a nuclear chymotrypsin-like protease activity (NCLPA), which appears to be involved in transformation in several different experimental models, is significantly elevated in keratinocytes infected with high-risk HPV.
View Article and Find Full Text PDFSpontaneous transformation of an immortalized hepatocyte cell line: potential role of a nuclear protease.
Cancer Lett
September 2004
Departments of Pathology and Biochemistry and Molecular Biology, The Jake Gittlen Cancer Research Institute, H059, Hershey Medical Center, The Pennsylvania State University, 500 University Drive, Hershey, PA 17033, USA.
In this study, we utilized an in vitro model of spontaneous transformation/progression, an SV40 large T antigen-immortalized rat hepatocyte cell line (designated CWSV14) that is very weakly tumorigenic at low-passage, but acquires a transformed phenotype upon extended passage in cell culture. Here we show that this mid-passage transformation is accompanied by development of aneuploidy and disorganization of the actin cytoskeleton, concomitant with a large increase in a chymotrypsin-like nuclear protease activity which we have previously implicated in chemical transformation of fibroblasts and ras-transformation of hepatocytes. Passage of the CWSV14 cells with AAPF(cmk), a relatively selective inhibitor of the nuclear protease activity, abrogates the acquisition of the transformed phenotype and prevents the changes in the actin cytoskeleton.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!